456% Rally in Just 2 Years! Why This Specialty Chemical Stock Will Remain in Focus on Monday

Sudarshan Pharma Industries share price is set to draw market attention on Monday. The company allotted 90 lakh equity shares after warrant conversion by promoter group members. Its paid-up share capital has now increased to ₹24.96 crore.

The small-cap stock, priced below ₹50, has gained strongly in recent months. It rose 22% in one month, 40% in three months, and 48% in six months. Over one year, however, the stock has added only 17%.

Sudarshan Pharma share price and recent stock movement

The scrip touched a 52-week high of ₹36.95 in May 2026. It had earlier reached a 52-week low of ₹18.50 in January 2026. These levels show a wide trading range during 2026.

The recent allotment followed the conversion of warrants issued on a preferential basis. These warrants were held by members of the promoter group. Sudarshan Pharma Industries Ltd approved the allotment through its Warrants Committee.

Sudarshan Pharma share price in focus after warrant conversion

The committee met on June 12, 2026, and cleared the conversion of 9 lakh warrants. These warrants were converted into 90 lakh fully paid-up equity shares. The move brought ₹11.46 crore into the company.

The company said the allotment would add strength to its capital base. It also increased the promoter group's stake in Sudarshan Pharma. After the allotment, promoters and the promoter group hold 58.93%.

Non-promoter shareholders now hold 41.07% of the company. The issued and paid-up share capital stands at ₹24.96 crore. This includes 24.96 crore equity shares with a face value of Re 1 each.

Sudarshan Pharma share price linked to promoter allotment details

The equity shares were issued at ₹16.983 per share. This price included a premium of ₹15.983 per share. The warrants had originally been issued at ₹169.83 each under preferential terms.

Promoters Hemal Vasantrai Mehta and Sachin Vasantrai Mehta carried out the conversion. Each converted 4.5 lakh warrants. Each promoter received 45 lakh equity shares after completing the warrant conversion process.

The promoters paid ₹127.37 for each warrant as the balance amount. This represented 75% of the warrant issue price. The total payment from both warrant holders stood at ₹11.46 crore.